{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:05:49Z","timestamp":1768442749336,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.semradonc.2007.02.001","type":"journal-article","created":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T11:12:58Z","timestamp":1182942778000},"page":"158-168","source":"Crossref","is-referenced-by-count":26,"title":["Cutaneous Lymphomas"],"prefix":"10.1016","volume":"17","author":[{"given":"Benjamin D.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn D.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2007.02.001_bib1","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin\u2019s lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2007.02.001_bib2","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1200\/JCO.2005.08.137","article-title":"The cutaneous B-cell lymphoma prognostic index: A novel prognostic index derived from a population-based registry","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib3","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2007.02.001_bib4","series-title":"Pathology and Genetics of Tumours of Hematopoietic and Lympoid Tissues","article-title":"Classification of Tumors","year":"2001"},{"key":"10.1016\/j.semradonc.2007.02.001_bib5","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2007.02.001_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1067\/mjd.2002.121355","article-title":"Practical evaluation and management of cutaneous lymphoma","volume":"46","author":"Fung","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00000478-199707000-00001","article-title":"The value of the polymerase chain reaction in the diagnosis of cutaneous T-cell infiltrates","volume":"21","author":"Ashton-Key","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00019606-200106000-00002","article-title":"The value of clonality in the diagnosis and follow-up of patients with cutaneous T-cell infiltrates","volume":"10","author":"Dadej","year":"2001","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib9","series-title":"AJCC Cancer Staging Handbook","author":"Greene","year":"2002"},{"key":"10.1016\/j.semradonc.2007.02.001_bib10","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.1996.03890350051009","article-title":"Clinical stage IA (limited patch and plaque) mycosis fungoides","volume":"132","author":"Kim","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib11","first-page":"276","article-title":"Mycosis fungoides and the Sezary syndrome","volume":"26","author":"Kim","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1200\/JCO.2001.19.3.779","article-title":"Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides","volume":"19","author":"de Coninck","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1995.01690210033005","article-title":"Prognostic factors in erythrodermic mycosis fungoides and the Sezary syndrome","volume":"131","author":"Kim","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib14","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0190-9622(99)70079-4","article-title":"Prognostic factor analysis in mycosis fungoides\/Sezary syndrome","volume":"40","author":"Diamandidou","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archderm.1996.03890250052009","article-title":"Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma","volume":"132","author":"Wasik","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib16","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood.V92.9.3376","article-title":"Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides","volume":"92","author":"Delfau-Larue","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2007.02.001_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1067\/mjd.2003.286","article-title":"Long-term implications of T-cell receptor gene rearrangement analysis by Southern blot in patients with cutaneous T-cell lymphoma","volume":"48","author":"Guitart","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.0022-202x.2001.01476.x","article-title":"Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas","volume":"117","author":"Beylot-Barry","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/path.1711700306","article-title":"Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides","volume":"170","author":"Bakels","year":"1993","journal-title":"J Pathol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1067\/mjd.2002.118538","article-title":"Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas","volume":"46","author":"Vonderheid","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1396-0296.2003.01647.x","article-title":"Mycosis fungoides: Radiation therapy","volume":"16","author":"Hoppe","year":"2003","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.semradonc.2007.02.001_bib22","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/0360-3016(83)90321-8","article-title":"Palliative radiation treatment of cutaneous mycosis fungoides\u2014A dose response","volume":"9","author":"Cotter","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2007.02.001_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0360-3016(97)00553-1","article-title":"Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (Mycosis Fungoides)","volume":"40","author":"Wilson","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2007.02.001_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1148\/119.2.439","article-title":"Dose-time fractionation study in patients with mycosis fungoides and lymphoma cutis","volume":"119","author":"Kim","year":"1976","journal-title":"Radiology"},{"key":"10.1016\/j.semradonc.2007.02.001_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0360-3016(98)00218-1","article-title":"Radiotherapy for unilesional mycosis fungoides","volume":"42","author":"Micaily","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl 1","key":"10.1016\/j.semradonc.2007.02.001_bib26","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.1016\/S0360-3016(03)01145-3","article-title":"Local superficial radiotherapy (LSRT) for newly diagnosed stage IA patch-plaque mycosis fungoides (MF) with only one, two, or three presenting lesions","volume":"57","author":"Wong","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2007.02.001_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1067\/mjd.2002.123482","article-title":"Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group","volume":"47","author":"Jones","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0360-3016(77)90182-1","article-title":"The rationale for curative radiotherapy in mycosis fungoides","volume":"2","author":"Hoppe","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2007.02.001_bib29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0360-3016(94)90103-1","article-title":"Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 GY","volume":"28","author":"Jones","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2007.02.001_bib30","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0889-8588(18)30058-3","article-title":"Electron beam treatment for cutaneous T-cell lymphoma","volume":"9","author":"Jones","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.semradonc.2007.02.001_bib31","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.ijrobp.2004.02.046","article-title":"Matching the dosimetry characteristics of a dual-field Stanford technique to a customized single-field Stanford technique for total skin electron therapy","volume":"59","author":"Chen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2007.02.001_bib32","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1088\/0031-9155\/48\/7\/306","article-title":"Composite depth dose measurement for total skin electron (TSE) treatments using radiochromic film","volume":"48","author":"Gamble","year":"2003","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0958-3947(02)00235-2","article-title":"Total skin electron irradiation: Evaluation of dose uniformity throughout the skin surface","volume":"28","author":"Anacak","year":"2003","journal-title":"Med Dosim"},{"key":"10.1016\/j.semradonc.2007.02.001_bib34","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0889-8588(03)00108-4","article-title":"Total skin electron beam radiotherapy for patients who have mycosis fungoides","volume":"17","author":"Jones","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.semradonc.2007.02.001_bib35","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1912::AID-CNCR23>3.0.CO;2-1","article-title":"Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy","volume":"77","author":"Quiros","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2007.02.001_bib36","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0360-3016(98)00517-3","article-title":"Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides","volume":"43","author":"Chinn","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2007.02.001_bib37","first-page":"1985","article-title":"Total skin electron radiation for patients with erythrodermic cutaneous T-cell lymphoma (mycosis fungoides and the Sezary syndrome)","volume":"85","author":"Jones","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2007.02.001_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0190-9622(96)90499-5","article-title":"Additional courses of total skin electron beam therapy in the treatment of patients with recurrent cutaneous T-cell lymphoma","volume":"35","author":"Wilson","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib39","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0360-3016(94)00590-H","article-title":"Multiple courses of high-dose total skin electron beam therapy in the management of mycosis fungoides","volume":"32","author":"Becker","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2007.02.001_bib40","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0360-3016(97)00127-2","article-title":"Total skin electron beam therapy followed by adjuvant psoralen\/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)","volume":"38","author":"Quiros","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2007.02.001_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1067\/mjd.2000.105510","article-title":"Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides","volume":"43","author":"Wilson","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib42","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0889-8588(03)00109-6","article-title":"Cytokine therapy of cutaneous T-cell lymphoma: Interferons, interleukin-12, and interleukin-2","volume":"17","author":"Rook","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.semradonc.2007.02.001_bib43","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/archderm.1979.04010090018015","article-title":"Electron beam therapy","volume":"115","author":"Price","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib44","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0360-3016(88)90306-9","article-title":"Total skin electron irradiation for mycosis fungoides: Relationship between acute toxicities and measured dose at different anatomic sites","volume":"15","author":"Desai","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2007.02.001_bib45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/archderm.1995.01690160060009","article-title":"Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma","volume":"131","author":"Licata","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib46","unstructured":"Smith BD, Wilson LD: Management of mycosis fungoides: Part 2. Treatment. Oncology (Huntingt) 17:1419-1428; discussion 1430, 1433, 2003"},{"key":"10.1016\/j.semradonc.2007.02.001_bib47","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2000.18.15.2908","article-title":"Primary cutaneous T-cell lymphoma: Review and current concepts","volume":"18","author":"Siegel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib48","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"CD30+ cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma","volume":"49","author":"Liu","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/0003-4819-122-3-199502010-00009","article-title":"Lymphomatoid papulosis: A T-cell dyscrasia with a propensity to transform into malignant lymphoma","volume":"122","author":"Cabanillas","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semradonc.2007.02.001_bib50","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2133.1992.tb00106.x","article-title":"The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas","volume":"126","author":"Beljaards","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib51","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2004.08.044","article-title":"Primary cutaneous B-cell lymphoma treated with radiotherapy: A comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems","volume":"22","author":"Smith","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib52","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: The Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib53","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B-cell lymphomas: A European multicenter study","volume":"19","author":"Grange","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib54","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood-2003-08-2726","article-title":"Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas","volume":"103","author":"Grange","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2007.02.001_bib55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.0303-6987.2005.00298.x","article-title":"Expression of the bcl-6 and MUM1\/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: A tissue microarray study","volume":"32","author":"Sundram","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib56","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0360-3016(02)04199-8","article-title":"Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma","volume":"55","author":"Eich","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2007.02.001_bib57","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/1097-0142(19910501)67:9<2311::AID-CNCR2820670918>3.0.CO;2-0","article-title":"Primary cutaneous B-cell lymphoma: A unique type of low-grade lymphoma","volume":"67","author":"Santucci","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2007.02.001_bib58","first-page":"49","article-title":"Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma","volume":"13","author":"Piccinno","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1200\/JCO.1996.14.2.549","article-title":"Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: A clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy","volume":"14","author":"Rijlaarsdam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2007.02.001_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-8140(99)00089-4","article-title":"Radiotherapy in the management of cutaneous B-cell lymphoma","volume":"52","author":"Kirova","year":"1999","journal-title":"Radiother Oncol"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429607000124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429607000124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T18:37:26Z","timestamp":1587667046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429607000124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1053429607000124"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2007.02.001","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}